These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 26108134)

  • 41. Relationship between Proton Pump Inhibitors and Adverse Effects in Hemodialysis Patients: A Systematic Review and Meta-Analysis.
    Zhang Y; Deng D; Zhang R; Yi J; Dong J; Sha L
    Kidney Blood Press Res; 2022; 47(9):545-555. PubMed ID: 35878597
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Proton-pump inhibitors and risk of fractures: an update meta-analysis.
    Zhou B; Huang Y; Li H; Sun W; Liu J
    Osteoporos Int; 2016 Jan; 27(1):339-47. PubMed ID: 26462494
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An approach to the diagnosis and management of a case presenting with recurrent hypomagnesemia secondary to the chronic use of a proton pump inhibitor.
    dos Santos LM; Guerra RA; Lazaretti-Castro M; Vieira JG; Portes Ede S; Dias-da-Silva MR
    Magnes Res; 2015 Dec; 28(4):136-45. PubMed ID: 26878253
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Proton pump inhibitors and histamine-2 receptor antagonists on the risk of pancreatic cancer: a systematic review and meta-analysis.
    Laoveeravat P; Thavaraputta S; Vutthikraivit W; Suchartlikitwong S; Mingbunjerdsuk T; Motes A; Nugent K; Rakvit A; Islam E; Islam S
    QJM; 2020 Feb; 113(2):100-107. PubMed ID: 31503318
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Proton pump inhibitors associated with an increased risk of mortality in elderly: a systematic review and meta-analysis.
    Song HJ; Seo HJ; Jiang X; Jeon N; Lee YJ; Ha IH
    Eur J Clin Pharmacol; 2024 Mar; 80(3):367-382. PubMed ID: 38147074
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Proton pump inhibitors and risk of fracture: a systematic review and meta-analysis of observational studies.
    Ngamruengphong S; Leontiadis GI; Radhi S; Dentino A; Nugent K
    Am J Gastroenterol; 2011 Jul; 106(7):1209-18; quiz 1219. PubMed ID: 21483462
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk Evaluation of Proton Pump Inhibitors for Panitumumab-Related Hypomagnesemia in Patients with Metastatic Colorectal Cancer.
    Katsura H; Suga Y; Kubo A; Sugimura H; Kumatani K; Haruki K; Yonezawa M; Narita A; Ishijima R; Ikesue H; Toi H; Takata N
    Biol Pharm Bull; 2024; 47(1):98-103. PubMed ID: 38171783
    [TBL] [Abstract][Full Text] [Related]  

  • 48. No consistent evidence of differential cardiovascular risk amongst proton-pump inhibitors when used with clopidogrel: meta-analysis.
    Kwok CS; Jeevanantham V; Dawn B; Loke YK
    Int J Cardiol; 2013 Aug; 167(3):965-74. PubMed ID: 22464478
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Proton Pump Inhibitor Use and Magnesium Concentrations in Hemodialysis Patients: A Cross-Sectional Study.
    Nakashima A; Ohkido I; Yokoyama K; Mafune A; Urashima M; Yokoo T
    PLoS One; 2015; 10(11):e0143656. PubMed ID: 26618538
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Proton-pump inhibitors do not influence serum magnesium levels in renal transplant recipients.
    Van Ende C; Van Laecke S; Marechal C; Verbeke F; Kanaan N; Goffin E; Vanholder R; Jadoul M
    J Nephrol; 2014 Dec; 27(6):707-11. PubMed ID: 24816563
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Meta-analysis of proton pump inhibitors induced risk of community-acquired pneumonia.
    Nguyen PA; Islam M; Galvin CJ; Chang CC; An SY; Yang HC; Huang CW; Li YJ; Iqbal U
    Int J Qual Health Care; 2020 Jun; 32(5):292-299. PubMed ID: 32436582
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Do proton pump inhibitors increase mortality? A systematic review and in-depth analysis of the evidence.
    Ben-Eltriki M; Green CJ; Maclure M; Musini V; Bassett KL; Wright JM
    Pharmacol Res Perspect; 2020 Oct; 8(5):e00651. PubMed ID: 32996701
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Magnesium Deficiency and Proton-Pump Inhibitor Use: A Clinical Review.
    William JH; Danziger J
    J Clin Pharmacol; 2016 Jun; 56(6):660-8. PubMed ID: 26582556
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increase in cetuximab-induced skin rash and hypomagnesemia in patients receiving concomitant treatment with proton pump inhibitors (PPIs): a possible drug interaction?
    Abu-Amna M; Bar-Sela G
    Cancer Chemother Pharmacol; 2019 Mar; 83(3):545-550. PubMed ID: 30547192
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Proton pump inhibitors therapy and the risk of pneumonia: a systematic review and meta-analysis of randomized controlled trials and observational studies.
    Wang CH; Li CH; Hsieh R; Fan CY; Hsu TC; Chang WC; Hsu WT; Lin YY; Lee CC
    Expert Opin Drug Saf; 2019 Mar; 18(3):163-172. PubMed ID: 30704306
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The relationship between proton pump inhibitor use and serum magnesium concentration among hemodialysis patients: a cross-sectional study.
    Misra PS; Alam A; Lipman ML; Nessim SJ
    BMC Nephrol; 2015 Aug; 16():136. PubMed ID: 26268579
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: a meta-analysis.
    Lo WK; Chan WW
    Clin Gastroenterol Hepatol; 2013 May; 11(5):483-90. PubMed ID: 23270866
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proton pump inhibitors and hospitalization with hypomagnesemia: a population-based case-control study.
    Zipursky J; Macdonald EM; Hollands S; Gomes T; Mamdani MM; Paterson JM; Lathia N; Juurlink DN
    PLoS Med; 2014 Sep; 11(9):e1001736. PubMed ID: 25268962
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gastric Cancer Risk in Patients with Long-Term Use of Proton Pump Inhibitors: A Systematic Review and Meta-Analysis of Observational and Interventional Studies.
    Pan S; Thrift AP; Akhdar G; El-Serag HB
    Dig Dis Sci; 2023 Sep; 68(9):3732-3744. PubMed ID: 37432532
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Should patients prescribed long-term low-dose aspirin receive proton pump inhibitors? A systematic review and meta-analysis.
    Tran-Duy A; Vanmolkot FH; Joore MA; Hoes AW; Stehouwer CD
    Int J Clin Pract; 2015 Oct; 69(10):1088-111. PubMed ID: 25846476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.